GENE ONLINE|News &
Opinion
Blog

2018-11-23| PartnerAsia-Pacific

Med X Tech Summit Asia (MEDTEX) 2018 – Overview of Day 2 Program

by Rajaneesh K. Gopinath
Share To
MEDTEX1200
Med X Tech Summit Asia

By Rajaneesh K. Gopinath, Ph.D.

Proudly co-organized by GeneOnline, the global biotech conference brings key opinion leaders comprising healthcare professionals and technology giants under one roof promoting scientific exchange and business partnerships. The event is to be held from Nov 29 – 30, 2018 at the Grande Luxe Banquet, Taipei, Taiwan.

The second day of MEDTEX 2018 boasts of two sessions, a morning session that covers expert panel discussions on state-of-the-art technologies in health security systems followed by lunch and a post lunch session on Global healthcare innovation strategy.

The following are some of the major highlights on the second day of the conference.

1) The inaugural panel discussion would focus on the rapidly growing technology of Blockchain and Electronic Health Security in Healthcare. Moderated by Yuan Yao, Chief Data Scientist at PwC, the discussion includes Mohammed Tayeb (Medicalchain), Alexandra Tinsman (NEM Foundation) and Emma Hossack (Extensia) as speakers.

The second panel discussion is on the topic of “Designing an Intelligent Healthcare Ecosystem. It is moderated by Ted Chang, CTO of Quanta Computer. Panel speakers Keren Priyadarshini (Microsoft), David Hansen (CSIRO), Vitaly Herasevich (Mayo Clinic) and Daniel Tse (Google AI) will grace us with their insights.

2) The Luncheon will witness the Highlights on Singapore Biotechnology Ecosystem and Innovation. Yan-Lin Lye of Cambridge consultants will participate and moderate the discussion that also includes Whye-Kei Lye (Nanyang Technological University), Johnson Chen (CapBridge/ClearBridge) and Hsien-Hui Tong (SGInnovate).

3) Dr. Pan-Chyr Yang, VP of IBMI will deliver the opening remarks of the third and final session of Med x Tech Summit Asia 2018. This session is one of the key features of the event where panel discussions will be held on the topic of Global Healthcare Innovation Strategy. Major highlights of the Bioinnovation stadium include discussions from Markus Kalousek from Novartis and Yong-Hui Shi from Medtronic China Venture Fund. Their discussions are expected to provide valuable inputs on how to build healthcare innovation cluster and startup strategy and how potential candidates are evaluated. Another main attraction is the talk by Karin Mayer Rubinstein who will share with us, their latest technology from Israel Advanced Technology Industries (IATI). Besides, countries like Australia, USA, and UK will address their own unique biotechnology ecosystems. The event will be concluded with the awarding ceremony of National Innovation Award 2018.

MEDTEX and Taiwan Healthcare+ Expo strategically connects IT, biotech, pharmaceuticals, precision medicine and health management industries with global biomedical innovators. GeneOnline and co-organizers have carefully handpicked the key opinion leaders from diverse industry backgrounds to provide a wholesome learning experience for attendees about the latest technology and market trends in addition to fostering industry partnerships. Healthcare and business professionals must take advantage of this opportunity.

To register for the event, please visit

https://www.eventbrite.com/e/medtex-med-x-tech-summit-asia-2018-tickets-50897919046

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Pharmacogenomics (PGx): Tailoring Medicine to Your Genes
2024-04-01
Major U.S. Organization BIO Severs Ties With Member WuXi AppTec Amid U.S. Government’s Security Concerns
2024-03-15
R&D
Mayo Clinic Researchers Invent Hypothesis-Driven AI for Cancer Research Breakthroughs
2024-03-14
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top